no longer been enabled for the MHH campus network. For (discounted) individual licenses, please contact beiersdorf.anne @ mh-hannover.de (Tel. 9839). Danger: In the case of private orders (without the

the world's first paper on the new XBB.1.5-based vaccine from Biontech. As part of the "COVID-19 Contact (CoCo)" study at the MHH, 53 MHH employees who received the vaccine were examined. Their immune response

protrusions: "The images allow us to see exactly whether a stent inserted for stabilization is fully in contact with the vessel wall or whether we still need to optimize the position," explains senior physician

maintained with this new device," explains Professor Arjang Ruhparwar, "moreover, it does not come into contact with the patient's blood. Patients don't have to take medication to thin their blood, the risk of

explains Dr. Klietz. Participants wanted For more information about the study, interested parties can contact RBD@mh-hannover.de . Author: Kirsten Pötzke

year, the team can apply for the third funding round. SERVICE: For further information , please contact Professor Dr. Dr. Axel Schambach, schambach.axel@mh-hannover.de , telephone (0511) 532-5170.

information, please visit the homepage www.RESIST-cluster.de. SERVICE: For further information, please contact Professor Dr Nico Lachmann, Lachmann.Nico@mh-hannover.de , telephone (0511) 532-5366.

academic self-administration were of great concern to him. Even after his retirement, he kept in close contact with "his" hospital and was often a guest there. He remembered the beginnings in Hanover with particular

euros over 36 months, will start at the beginning of 2023. SERVICE: For further information , please contact Professor Dr Sascha David, david.sascha@mh-hannover.de , and Privatdozent Dr Klaus Stahl, stahl.

in standard care to all seriously ill children in the future." SERVICE: For more information , contact Dr. Bernd Auber, auber.bernd@mh-hannover.de , phone (0511) 532-8719.